$COGT
Cogent Biosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Waltham, MA
COGT chart
What traders are saying about $COGT
Latest postsCogent Biosciences, Inc. news
- Cogent Biosciences to present at Guggenheim Hea...
Pluang ·
- Cogent Biosciences to Participate in the Guggenheim Healthcare Innovation Conference
Yahoo Finance ·
- Trading Systems Reacting to (COGT) Volatility
Stock Traders Daily ·
- If You Invested $1000 In Cogent Biosciences Stock 5 Years Ago, You Would Have This Much Today
Benzinga ·
- Cogent Biosciences (COGT) Nears Three FDA Decisions. What Is Its Pipeline Worth?
Yahoo Finance ·
- Cogent Biosciences (COGT) Stock Trades At A Premium As FDA Accepts NDA
Yahoo Finance ·
- Cogent Biosciences (COGT) Looks Fully Valued Following FDA NDA Acceptance
Yahoo Finance ·
- Will FDA’s Streamlined Bezuclastinib Review in ASM Change Cogent Biosciences’ (COGT) Narrative?
Yahoo Finance ·
- Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) for Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
Yahoo Finance ·
- Cogent Biosciences (COGT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Yahoo Finance ·
- Cogent Bioscience (COGT) Files New Drug Application For Bezuclastinib
Yahoo Finance ·
- MEDevice Boston 2026: East Coast's Top Medical Device Conference Opens Registration for August 26-27 Event
Yahoo Finance ·
Cogent Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$328.9M | -$255.9M | -$192.4M | -$140.2M |
| Diluted EPS | $-2.16 | $-1.94 | $-1.94 | $-1.73 |
| Total assets (year end) | $937.6M | $327.9M | $313.4M | $300.8M |
| Cash and equivalents (year end) | $312.0M | $98.2M | $53.2M | $139.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cogent Biosciences, Inc.
- Ticker
- COGT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1622229
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
Frequently asked questions
What exchange is Cogent Biosciences, Inc. listed on?
Cogent Biosciences, Inc. trades on the Nasdaq under the ticker symbol COGT.
What industry is Cogent Biosciences, Inc. in?
Cogent Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Cogent Biosciences, Inc. headquartered?
Cogent Biosciences, Inc.'s business address on file with the SEC is in Waltham, MA.
When does Cogent Biosciences, Inc.'s fiscal year end?
Cogent Biosciences, Inc.'s fiscal year ends on December 31.